EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Transcatheter Repair in Posterior, Anterior, and Bileaflet Mitral Valve Disease

Saibal Kar, Matthew J Price, M Andrew Morse, Michael J Rinaldi, Paul Mahoney, Paolo Denti, Federico M Asch, Jose L Zamorano, Janani Aiyer, Rong Huang, Francesco Maisano, Ralph Stephan von Bardeleben und 1 weitere

JACC: Cardiovascular Interventions · 2025

DOI: 10.1016/j.jcin.2024.12.023 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift JACC: Cardiovascular Interventions, 2025. Verfasst von Saibal Kar und 12 weiteren Autor:innen. Beteiligte Einrichtung: Los Robles Regional Medical Center, HCA Healthcare, Thousand Oaks, California, USA. Electronic address: saibalkar60@gmail.com. Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Mitral Valve, Cardiac Catheterization, Mitral Valve Prolapse. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Abbott Structural Heart.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Treating anterior and bileaflet mitral valve disease in patients with primary or degenerative mitral regurgitation (DMR) is considered more challenging than posterior leaflet repair. OBJECTIVES: The aim of this analysis was to evaluate the impact of anterior, posterior, or bileaflet disease on outcomes following mitral transcatheter edge-to-edge repair (M-TEER) in the EXPANDed studies. METHODS: EXPANDed is a pooled, patient-level analysis of subjects undergoing M-TEER with the MitraClip G3 or G4 system as part of the contemporary EXPAND and EXPAND G4 studies. Subjects with DMR were categorized according to echocardiography core laboratory-assessed prolapse or flail location into posterior (prolapse or flail at P1, P2, and/or P3), anterior (prolapse or flail at A1, A2, and/or A3) or bileaflet disease (prolapse or flail at any combination of A1, A2, and A3 and P1, P2, and P3). Key outcomes assessed included procedural outcomes, 30-day major adverse events, and 1-year mitral regurgitation (MR) severity. RESULTS: Of 2,205 subjects in EXPANDed, 556 had echocardiography core laboratory-assessed DMR and prolapse or flail location. A total of 389 had posterior, 106 had anterior, and 61 had bileaflet disease. All groups experienced low device and procedure times with high procedural success rates (defined as discharge MR ≤2+). Thirty-day major adverse events rates were low across all groups (posterior, 4.4% [17 of 388]; anterior, 3.8% [4 of 105]; bileaflet, 6.6% [4 of 61]; P = 0.65). Through 1 year, all groups showed a significant reduction in MR severity from baseline (MR ≤1+ posterior, 82% [179 of 219]; anterior, 93% [53 of 57]; bileaflet, 97% [28 of 29]). CONCLUSIONS: Results from the EXPANDed studies demonstrate that subjects with DMR treated with M-TEER experienced significant improvements in outcomes, regardless of the location of prolapse or flail.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitral Valve InsufficiencyMitral ValveCardiac CatheterizationMitral Valve ProlapseHeart Valve Prosthesis ImplantationHumansTreatment OutcomeFemaleMaleAgedTime FactorsRisk FactorsSeverity of Illness IndexRecovery of FunctionAged, 80 and overMiddle AgedHeart Valve ProsthesisHemodynamics

Stichwörter der Autor:innen

M-TEERMitraClipmitral regurgitationmitral transcatheter edge-to-edge repairmitral valve repair

Autor:innen und Institutionen

  • Los Robles Regional Medical Center, HCA Healthcare, Thousand Oaks, California, USA. Electronic address: saibalkar60@gmail.com.
  • Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California, USA.
  • Ascension Saint Thomas, Nashville, Tennessee, USA.
  • Atrium Health, Charlotte, North Carolina, USA.
  • Division of Cardiology, Department of Cardiovascular Services, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA.
  • San Raffaele University Hospital, Milan, Italy.

Förderung

  • Abbott Structural Heart

Zitieren

APA

Kar, S., Price, M. J., Morse, M. A., Rinaldi, M. J., Mahoney, P., Denti, P., Asch, F. M., Zamorano, J. L., Aiyer, J., Huang, R., Maisano, F., von Bardeleben, R. S., & Rodriguez, E. (2025). Transcatheter Repair in Posterior, Anterior, and Bileaflet Mitral Valve Disease. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2024.12.023

Vancouver

Kar S, Price MJ, Morse MA, Rinaldi MJ, Mahoney P, Denti P, et al. Transcatheter Repair in Posterior, Anterior, and Bileaflet Mitral Valve Disease. JACC: Cardiovascular Interventions. 2025. doi:10.1016/j.jcin.2024.12.023

BibTeX
@article{Kar2025,
  author = {Kar, Saibal and Price, Matthew J and Morse, M Andrew and Rinaldi, Michael J and Mahoney, Paul and Denti, Paolo and Asch, Federico M and Zamorano, Jose L and Aiyer, Janani and Huang, Rong and Maisano, Francesco and von Bardeleben, Ralph Stephan and Rodriguez, Evelio},
  title = {Transcatheter Repair in Posterior, Anterior, and Bileaflet Mitral Valve Disease},
  journal = {JACC: Cardiovascular Interventions},
  year = {2025},
  doi = {10.1016/j.jcin.2024.12.023}
}
Kostenlos starten →